Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Nom du journal : Br J Cancer

Année : 2011

Volume : 104

Page de départ : 1544

Page de fin : 1550

Auteurs: Penel N, Glabbeke MV, Mathoulin-Pélissier S, Judson I, Sleijfer S, Bui BN, Schöffski P, Ouali M, Marréaud S, Brouste V, Duhamel A, Hohenberger P, Blay JY, Duhamel A,